Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
Clinical trial NCT05541445 · UNKNOWN
Trial details
- NCT number
- NCT05541445
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.